Expression and prognostic significance of activated caspase-3 (CASP3) in malignant pleural mesothelioma (MPM)

被引：0
|
作者：
Klabatsa, A
Fennell, DA
Evans, MT
Steele, JPC
Shamash, J
Rudd, RM
Sheaff, MT
机构：
[1] Barts & London Queen Mary Sch Med & Dent, Inst Cell & Mol Sci, London, England
[2] Barts & London NHS Trust, Dept Med Oncol, London, England
来源：
JOURNAL OF PATHOLOGY | 2005年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [31] Expression and prognostic significance of catalase in malignant mesothelioma
    Kahlos, K
    Soini, Y
    Sormunen, R
    Kaarteenaho-Wiik, R
    Pääkkö, P
    Linnainmaa, K
    Kinnula, VL
    CANCER, 2001, 91 (07) : 1349 - 1357
  • [32] PI3K pathway and downstream signaling analysis in malignant pleural mesothelioma (MPM)
    Cedres Perez, S.
    Montero, M. A.
    Torrejon, D.
    Martinez, P.
    Freixinos, V.
    Mulet-Margalef, N.
    Argiles, G.
    Nunez, I.
    Lopez, E.
    Prudkin, L.
    Salcedo, M.
    Tallada, N.
    Ramon y Cajal, S.
    Felip, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
    Pinelli, Valentina
    Fini, Donatella
    Battolla, Enrico
    Ferro, Paola
    Franceschini, Maria Cristiana
    Fontana, Vincenzo
    Pistillo, Maria Pia
    Roncella, Silvio
    Canessa, Pier Aldo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] ACTIVATION OF CASPASE-3 IN MALIGNANT MESOTHELIOMA INDUCED BY ASBESTIFORM FIBER: AN IN VIVO STUDY
    Loreto, C.
    Ledda, C.
    Tumino, R.
    Lombardo, C.
    Vitale, E.
    Filetti, V.
    Caltabiano, R.
    Rapisarda, V.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (03): : 1163 - 1166
  • [35] Fibulin-3: A Potential Prognostic Biomarker in Malignant Pleural Mesothelioma?
    Kirschner, Michaela B.
    Pulford, Emily
    Hoda, Mir A.
    Rozsas, Anita
    Griggs, Kim
    Edelman, J. James B.
    Kao, Steven
    Hyland, Rebecca
    Dong, Yawen
    Laszlo, Viktoria
    Klikovits, Thomas
    Jakopovic, Marko
    Vallely, Michael
    Grusch, Michael
    Hegedus, Balazs
    Dome, Balazs
    Klepetko, Walter
    Van Zandwijk, Nico
    Klebe, Sonja
    Reid, Glen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S747 - S747
  • [36] Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
    De Fonseka, Duneesha
    Arnold, David
    Morley, Anna
    Daly, Richard
    Bhatt, Nidhi
    Edey, Anthony
    Maskell, Nick
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] Expression and prognostic significance of hypoxia-inducible factor 1 alpha in malignant pleural mesothelioma
    Klabatsa, A
    Fennell, DA
    Evans, MT
    Shamash, J
    Steele, JPC
    Rudd, RM
    Sheaff, MT
    JOURNAL OF PATHOLOGY, 2003, 201 : 49A - 49A
  • [38] Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection
    Huang, Hua
    Zhang, Xiao-Fei
    Zhou, Hai-Jun
    Xue, Yu-Hua
    Dong, Qiong-Zhu
    Ye, Qing-Hai
    Qin, Lun-Xiu
    CANCER SCIENCE, 2010, 101 (05) : 1314 - 1319
  • [39] PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN A COHORT OF PATIENTS COMPENSATED BY THE DUST DISEASES BOARD
    Kao, Steven C.
    Clarke, Stephen
    Chatfield, Mark
    Corte, Peter
    Clarke, Christopher
    Vardy, Janette
    Van Zandwijk, Nico
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1376 - S1376
  • [40] Prominent Expression of the Negative Immune Checkpoint Regulator VISTA in Malignant Pleural Mesothelioma (MPM)
    Muller, Stephanie
    Zauderer, Marjorie
    Desmeules, Patrice
    Jungbluth, Achim
    Fayad, Miriam
    Frosina, Denise
    Ni, Ai
    Ladanyi, Marc
    Sauter, Jennifer L.
    MODERN PATHOLOGY, 2018, 31 : 743 - 743
12345